Clinical Trials Browser

Phase 1/2 × Interventional × VT-464 × Clear all

NCT02361086 2019-02-01

A Study to Evaluate Once-Daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer

Phase 1/2 Completed

Castration-resistant Prostate Cancer